Stage III should be subclassified into Stage IIIA and IIIB in the American Joint Committee on Cancer (8th Edition) staging system for pancreatic cancer

doi:10.3748/wjg.v24.i22.2400

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6037)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

382

HTML

3332

Figures (1-2)

267

Tables (1-3)

219

Sum=4200

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

811

Download

1026

Sum=1837

Jun 14, 2018 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jun 14, 2018; 24(22): 2400-2405
Published online Jun 14, 2018. doi: 10.3748/wjg.v24.i22.2400

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Meier analysis of overall survival in stage III pancreatic cancer patients. There was no significant difference between the T(1-3)N2 and T4N(0-1) groups (P = 0.229). However, compared with stage T4N2, the OS curve of T(1-3)N2/T4N(0-1) was significantly better [stage T(1-3)N2 vs T4N2: P = 0.019; stage T4N(0-1) vs T4N2: P = 0.009; stage T(1-3)N2 + T4N(0-1) vs T4N2: P = 0.015]. OS: Overall survival.

Open in New Tab Full Size Figure Download Figure

Figure 2 Kaplan-Meier analyses of disease-specific survival N stage III pancreatic cancer patients. There was no significant difference between the T(1-3)N2 and T4N(0-1) groups (P = 0.124). However, compared with stage T4N2, the DSS curve of T(1-3)N2/T4N(0-1) was significantly better [stage T(1-3)N2 vs T4N2: P = 0.014; stage T4N(0-1) vs T4N2: P = 0.003; stage T(1-3)N2 + T4N(0-1) vs T4N2: P = 0.011]. DSS: Disease-specific survival.

Citation: Yu HF, Zhao BQ, Li YC, Fu J, Jiang W, Xu RW, Yang HC, Zhang XJ. Stage III should be subclassified into Stage IIIA and IIIB in the American Joint Committee on Cancer (8^th Edition) staging system for pancreatic cancer. World J Gastroenterol 2018; 24(22): 2400-2405
URL: https://www.wjgnet.com/1007-9327/full/v24/i22/2400.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i22.2400